# Apotex, Inc. BioClinical Development Clinical Operations Department – FDA Inspection, Jan 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/apotex-inc-bioclinical-development-clinical-operations-department/081dfea0-ae7f-4e63-9c3a-5a3908c323c7
Source feed: FDA_Inspections

> FDA inspection 1002932 of Apotex, Inc. BioClinical Development Clinical Operations Department, January 13, 2017. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002932
- Company Name: Apotex, Inc. BioClinical Development Clinical Operations Department
- Inspection Date: 2017-01-13
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1005519 - 2017-02-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/hasan-a-irier/8757c2d5-77b0-45a7-b0f2-e42ef3ee306f)
- [Company Rep](https://www.keypedia.com/people/sripal-r-mada/38ce7c12-1405-436b-ac3e-55149c953537)

Company: https://www.keypedia.com/companies/apotex-inc-bioclinical-development-clinical-operations-department/f69d2ce8-d899-45bb-93f7-a75b3e6a8702

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8